Author:
Webendoerfer Maximilian,Konik Margarethe,Zettler Markus,Wienker Johannes,Rawitzer Josefine,Esser Stefan,Kehrmann Jan,Herrmann Ken,Reinhardt Hans Christian,Witzke Oliver,Dolff Sebastian
Abstract
Abstract
Introduction
Granulomatosis due to immune reconstitution inflammatory syndrome (IRIS) and disseminated Mycobacterium avium-intracellulare (M. avium) infection may trigger hypercalcemia. Here, we report a rare case of hypercalcemia and acute kidney damage related to IRIS in a person living with Human Immunodeficiency Virus (HIV).
Case presentation
A 39-year-old male person living with HIV presented with muscle weakness and unwanted weight loss of 8 kg within the last 2 weeks. Laboratory findings included serum hypercalcemia of 3.27 mmol/mL associated with elevated calcitriol and acute kidney damage. Since the first diagnosis of HIV and concomitant disseminated M. avium infection, the patient received antiretroviral therapy (ART), rifabutin, clarithromycin, and ethambutol. 18Fluoro-D-glucose positron emission computed tomography (18FDG-PET/CT) showed progressive multilocular lymphadenopathy. Biopsy specimen from the duodenum as well as retroperitoneal and mediastinal lymph nodes revealed granulomatous inflammation consistent with IRIS. Treatment with forced diuresis, bisphosphonates, and calcitonin normalized serum calcium and kidney function recovered.
Conclusion
Hypercalcemia due to IRIS is a rare differential diagnosis in persons living with HIV and may lead to acute kidney damage, despite sufficient ART and antimycobacterial treatment.
Funder
Gilead Sciences
AstraZeneca
Universitätsklinikum Essen
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. WHOint. 2016; https://iris.who.int/handle/10665/208825. Accessed 23 Feb 2024.
2. Walker MD, Shane E. Hypercalcemia. JAMA. 2022;328:1624. https://doi.org/10.1001/jama.2022.18331.
3. Nongnuch A, Petcharut J, Suksuwan W, Davenport A, Phuphuakrat A. Causes of hypercalcemia in people living with HIV in the HAART era. HIV Res Clin Pract. 2020;21:115–20. https://doi.org/10.1080/25787489.2020.1836900.
4. Thongprayoon C, Cheungpasitporn W, Mao MA, Sakhuja A, Erickson SB. Admission calcium levels and risk of acute kidney injury in hospitalised patients. Int J Clin Pract. 2018;72: e13057. https://doi.org/10.1111/ijcp.13057.
5. Maurer MJ, Ghesquières H, Jais JP, Witzig TE, Haioun C, Thompson CA, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32:1066–73. https://doi.org/10.1200/jco.2013.51.5866.